Research
Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.
Amplica Bio SEC Form D Review 2026: $30K Stealth Biotech Raise, Harvard-MIT Founders and the Amplifica Name Trap
Amplica Bio, Inc. is a newly formed Delaware biotechnology company whose first SEC Form D provides very little capital but unusually useful identity evidence. The September 11 filing reports an indefinite offering, $30,000 sold to one investor following a September 2 first sale, and securities consisting of both Equity
Amplica Bio, Inc. · CIK 0002154543Read article →
Is ISQ Global InfraTech Fund II, L.P. Legit? SEC Form D Review 2026: $30M Sold, 2 Investors and I Squared's Physical-AI Infrastructure Strategy
ISQ Global InfraTech Fund II, L.P. is a verifiable 2024 Cayman Islands pooled investment fund managed through I Squared Capital's Miami infrastructure platform. Its September 14, 2026 SEC Form D/A reports an indefinite offering with $30,000,000 sold to two investors, a first sale on April 22, 2026, Rule 506(b), Section 3(c)(7), equity and pooled investment fund interests, no outside placement agent, $0 sales commissions and $0 finder's fees. ISQ Global InfraTech Fund II GP, LLC is the General Partner, I Squared Capital Advisors (US) LLC is explicitly identified as Investment Manager, and I Squared co-founders Sadek Wahba and Gautam Bhandari appear as executive officers; Bhandari signed the amendment as manager of the sole member of the General Partner. The filing also states that confidential offering materials describe fees payable to the Investment Manager and General Partner. The most important point is that the $30 million figure is cumulative securities sold by this legal vehicle, not the size of I Squared's entire InfraTech strategy and certainly not I Squared's firmwide AUM. The real research story is how a global infrastructure manager is using a dedicated technology fund to invest in companies whose software, AI, satellites, energy systems and industrial technology increasingly behave like infrastructure.
ISQ Global InfraTech Fund II, L.P. · CIK 0002034251Read article →
Is Polpo Capital Offshore LP Legit? SEC Form D Review 2026: $15.18M Offshore Feeder, $73.85M U.S. Fund and Dan McNamara's CMBS Distress Strategy
Polpo Capital Offshore LP is a verifiable Cayman hedge-fund vehicle managed from Polpo Capital's Hastings-on-Hudson, New York platform, and its September 18, 2026 Form D/A reports $15,181,988 sold to 12 investors in an indefinite Rule 506(b) offering with a $100,000 minimum investment. The fund relies on Section 3(c)(7), offers equity and pooled investment fund interests, reports $0 sales commissions and $0 finder's fees, and identifies Daniel John McNamara as sole member of the issuer's General Partner, Polpo Capital GP LLC. The same filing also identifies The Distinction Group / INTE Securities and Piper Sandler as solicitation participants even though Item 15 reports no commission expense. The most important point is that this offshore vehicle is only one sleeve of Polpo's fund architecture: the domestic Polpo Capital LP reported $73,851,030 sold in its latest October 2025 amendment, while Polpo Capital Management's 2026 adviser data show approximately $299.5 million of regulatory AUM and about $209.5 million of private-fund gross assets. Those figures describe different layers — feeder sales, domestic fund sales, private-fund GAV and adviser RAUM — and should never be collapsed into one synthetic AUM number.
Polpo Capital Offshore LP · CIK 0001943756Read article →
Therapeutic Neuromodulation Systems SEC Form D Review 2026: $5M Raise, 6 Non-Accredited Investors and the Morph Device FDA Question
Therapeutic Neuromodulation Systems LLC is not a newly created neuromodulation startup despite appearing in SEC EDGAR under a new 2026 CIK record. Its September 11 Form D identifies a Louisiana LLC organized more than five years ago and, unusually, reports a first sale date of October 15, 2017. The current offering is
Therapeutic Neuromodulation Systems LLC · CIK 0002152054Read article →
Is Propel(x) Syndicates LLC - Grep VC Surgimatix Legit? SEC Form D Review 2026: $2.355M Fully Sold, 34 Investors and an FDA-Cleared Surgical Device SPV
Propel(x) Syndicates LLC - Grep VC Surgimatix is a verifiable 2026 Delaware venture-capital SPV that moved from first sale to a fully subscribed offering almost immediately. The September 18, 2026 Form D reports a fixed $2,355,000 offering, the full $2,355,000 sold to 34 investors, $0 remaining, a $10,000 minimum investment and a first sale on September 17 — only one day before the filing. The vehicle relies on Rule 506(b) and Section 3(c)(1), offers pooled investment fund interests, reports no broker-dealer, $0 sales commissions, $0 finder's fees and $0 related-person use of proceeds, and identifies Tim Kelly as President. Its principal address is 1 East Liberty, Suite 600, Reno, Nevada, with the same 833-277-6735 telephone number used by Propel(x)'s current operating infrastructure. Unlike anonymous numbered SPVs, this legal name gives investors two unusually strong clues about the underlying transaction: "Grep VC" and "Surgimatix." The company-side match is especially strong because Surgimatix is an independently verifiable medical-device company with an FDA-cleared soft-tissue fixation platform and a commercialization program extending back years.
Propel(x) Syndicates LLC - Grep VC Surgimatix · CIK 0002154847Read article →
Ellipsys Medical SEC Form D Review 2026: $5.91M Raised to Relaunch a Medtronic-Abandoned Dialysis Device
Ellipsys Medical, Inc. is a newly formed Delaware medical-device company whose 2026 financing is tied to an unusually mature underlying product. The September 17 Form D amendment reports a fixed $10.85 million Equity offering under Rule 506(b), with $5,906,665 sold to 39 investors and $4,943,335 remaining after first s
Ellipsys Medical, Inc. · CIK 0002153524Read article →
01 Labs SEC Form D Review 2026: The $1M Uncapped SAFE and the Unusual $100 Valuation-Cap Structure
01 Labs, Inc. is a verifiable Nevada technology corporation formed in 2026, and its September 2 Form D contains one of the most unusual SAFE structures in this recent filing set. The company reported a fixed $1,000,002 offering, the full amount sold, $0 remaining and three investors following a first sale on August 20.
01 Labs, Inc. · CIK 0002135437Read article →
Onto AI SEC Form D Review 2026: $100M Debt Fully Sold to 6 Investors With a $10M Minimum
Onto AI LLC is a verifiable Delaware technology issuer whose first public SEC filing is unusually large and unusually concentrated. The September 8, 2026 Form D reports a fixed $100,000,000 offering, the full $100,000,000 already sold, $0 remaining and only six investors after a first sale on September 4. Unlike the ve
Onto AI LLC · CIK 0002153461Read article →
Is Overlook X1 LP - Series E1A Legit? SEC Form D Review 2026: $350K Fully Sold, Mannsion Group and the Multi-Series Late-Stage Private Market Structure
Overlook X1 LP - Series E1A is a verifiable 2026 Delaware private-equity vehicle managed from The Mannsion Group's White Plains, New York platform. Its September 18, 2026 Form D reports a fixed $350,000 offering that was fully sold to two investors, leaving $0 remaining, with a July 24, 2026 first sale and a $250,000 minimum investment. The vehicle relies on Rule 506(b) and Section 3(c)(7), offers pooled investment fund interests, reports no sales commissions or finder's fees and does not identify an outside placement agent. David Samuel Mann is listed as an executive officer, The Mannsion Group LLC as promoter and investment manager, and the same 445 Hamilton Avenue, Suite 1500 address and 732-484-0972 phone number recur throughout the broader Overlook X1 filing family. The defining research story is not this small $350,000 sleeve by itself: Overlook X1 has appeared during 2026 through several separately filed series with radically different sizes, investor counts and distribution arrangements, showing that Mannsion is using a modular series architecture for distinct late-stage private-market allocations rather than operating one conventional blind-pool fund.
Overlook X1 LP - Series E1A · CIK 0002155670Read article →
Is SRS Long Opportunities, LP Legit? SEC Form D Review 2026: $1.279B Sold, 105 Investors and SRS's Concentrated Long-Equity Structure
SRS Long Opportunities, LP is a verifiable Delaware pooled investment fund managed by SRS Investment Management, LLC, and its latest September 18, 2026 Form D/A shows a substantial long-running capital base rather than a newly launched vehicle. The fund reports an indefinite Rule 506(b) offering with $1,279,498,056 sold to 105 investors, Section 3(c)(7) status, a first sale dating back to October 1, 2015, no disclosed placement agent, $0 sales commissions and $0 finder's fees. SRS Long Opportunities GP, LLC is the General Partner, SRS Investment Management is identified as Investment Manager and promoter, and David B. Zales signed the amendment as General Counsel and CCO of the Investment Manager. The filing also states that the fund charges a management fee described in its private offering documents. The most important 2026 insight is that the U.S. LP is only one sleeve of a broader Long Opportunities structure: the parallel Cayman vehicle, SRS Long Opportunities, Ltd., filed an amendment the same day showing $579,511,318 sold to 40 investors and a $100,000 minimum. The two amounts should not automatically be combined and called current NAV or AUM, but together they reveal a substantial parallel domestic/offshore capital architecture. :contentReference[oaicite:0]{index=0}
SRS Long Opportunities, LP · CIK 0001654155Read article →
Is Corriente-Phantom Space Fund, LP Legit? SEC Form D Review 2026: $1M Fully Sold, Corriente's Direct Space Bet and Phantom's Vector Launch Asset Deal
Corriente-Phantom Space Fund, LP is a verifiable 2026 Delaware pooled investment vehicle whose September 10, 2026 SEC Form D reports a fixed $1,000,000 offering fully sold to a single investor. The fund relies on Rule 506(b) and Section 3(c)(1), reported a first sale on August 11, 2026, offers pooled investment fund interests, shows a technical $0 minimum investment, and reports no broker-dealer, sales commissions, finder's fees or related-person use of proceeds. Corriente Advisors, LLC is identified directly as the General Partner and promoter, using 1401 Foch Street, Suite 100 in Fort Worth. The strongest differentiator is unusually obvious from the legal name itself: unlike many SPVs where the underlying asset has to be inferred, this issuer explicitly names Phantom Space, making the sponsor-to-target relationship highly visible. Public evidence then adds a second layer: Corriente's founder Mark Hart has publicly described Phantom Space as a particularly compelling commercial-space opportunity and expressed direct support for the company, while former Corriente partner Worth Wray moved from investor/adviser around Phantom into Phantom's Chief Strategy Officer role and, in August 2026, became Chief Operating Officer. :contentReference[oaicite:0]{index=0}
Corriente-Phantom Space Fund, LP · CIK 0002153820Read article →
Every Media SEC Form D Review 2026: One Investor Bought Nearly $16M as Every Shifted From Newsletter to AI Product Studio
Every Media, Inc. is a verifiable Delaware operating technology company, and its September 8, 2026 Form D documents a dramatic change in the financing model that CEO Dan Shipper publicly described only a year earlier. The filing reports a fixed $16,474,903 Equity offering under Rule 506(b), with $15,999,909 already sol
Every Media, Inc. · CIK 0002152342Read article →